Get startedLog in
    Picture of Gyre Therapeutics logo

    GYRE — Gyre Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapNeutral
    All News

    Brief: Catalyst Biosciences Reports First Quarter 2022 Operating & Financial Results

    Picture of Gyre Therapeutics logoGyre Therapeutics
    09/05/2022 14:01
    May 9 (Reuters) - Catalyst Biosciences Inc  CBIO.O :
    * CATALYST BIOSCIENCES REPORTS FIRST QUARTER 2022 OPERATING
&
FINANCIAL RESULTS
    * Q1 LOSS PER SHARE $0.46
    * CASH AND CASH EQUIVALENTS AS OF MARCH 31, 2022, WERE $34.8
MILLION

Source text for Eikon:  ID:nGNX1Q7rQ9 
Further company coverage:  CBIO.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Gyre Therapeutics

    See all news